BioGlue revenues

Related by string. * : BioGlue Surgical Adhesive . BioGlue ® . BioGlue . BioGlue R / Revenues . REVENUE . REVENUES . - Revenues [015] . reve nue . reve nues . Revenue . - Revenues [021] . - Revenues [010] . - Revenues [007] : Her Majesty Revenue . Internal Revenue Code . Internal Revenue BIR . Internal Revenue Service . revenue refunding bonds . Revenue Per . HM Revenue & . HM Revenue . revenues * *

Related by context. Frequent words. (Click for all words.) 66 Noninterest expense decreased 64 4Q FY# 64 PTOI 64 FQ = fiscal 64 Engineered Products segment 64 Gross Profit Gross 64 3Q FY# 63 1Q FY# 63 Non GAAP adjusted EBITDA 62 Chemicals Segment 62 Operating Expenses Operating 62 Fully diluted EPS 62 Retail Leathercraft 61 Overall NewMarket 61 BioMarin Genzyme LLC 61 thethird quarter 61 fracture proppants 61 ofapproximately 61 comparedto 60 Interest expense decreased 60 dental reconstructive 60 Including discontinued operations 60 BioGlue R 60 Novogyne 60 quarterof 59 2Q FY# [001] 59 Nonperforming assets totaled 59 Angio Seal TM 59 Normalized EBITDA 58 pershare 58 Ps.2 58 anincrease 58 Harland Acquisition 58 #GB FireWire Ext 57 Its ROA 57 #.#bn rub [003] 57 Inland Barge Group 57 Fully diluted earnings 57 Revenue Trades DARTs 57 ended December# 57 Q2 FY# [001] 57 Gross margin 57 NASDAQ OSIR 57 US#.#m [002] 57 Statscan revised 57 PV module shipments 57 Segment EBIT 57 Q3 FY'# 57 Projections ranged 56 excluding nonrecurring items 56 Gross margins 56 AZASITE 56 DRDGold Ltd. DROOY 56 WhiteWave Morningstar 56 FQ#'# 56 JPY#.# billion [002] 56 intersegment revenues 56 World J Gastroenterol 56 AlloDerm 56 pro forma adjusted EBITDA 55 NMP# R 55 USD #.#bln [001] 55 Invested assets 55 Funded backlog 55 CHF#.# [001] 55 to#.# [006] 55 Subsea Products 55 J Thorac Cardiovasc Surg 55 normalized FFO 55 Underlying EBIT 55 Operating netbacks 55 Medication Delivery 55 Underlying pretax 55 YTD Fiscal 55 gross margin 55 ONEOK Partners segment 55 Q1 FY'# 55 tissue grafts 55 EBIT amounted 55 per MCFE 55 RMB#.# billion [001] 55 #.#/BOE [001] 55 unfavorable variance 55 PY EUR 55 Consolidated adjusted EBITDA 55 intangible impairment 54 RMB#.# [007] 54 LIFO inventory valuation 54 minimally invasive ophthalmic 54 NTD#.# USD1 54 RMB1 #.# 54 Exacta £ 54 Macroplastique 54 #.#ma [005] 54 Clearant 54 Seamap 54 Thrombin 54 GBP #.#m [003] 54 diluted share 54 LIFO expense 54 Adjusted Diluted EPS

Back to home page